Meeting
Abstract Number: 78
Hospital Medicine 2017, May 1-4, 2017; Las Vegas, Nev.
Background: The randomized controlled ANZ-STATInS trial demonstrated that de novo statin use did not alter interleukin-6 levels or Sequential Organ Failure Assessment (SOFA) score in of what before SEPSIS-3 was known as severe sepsis. Prospective observational studies indicate that prior statin use sepsis is associated with a decreased rate of severe sepsis. We aimed to […]